Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dioxolane analogues of uridine for the treatment of cancer

Dioxolane analogues of uridine for the treatment of cancer

US Patent 10654877 · Granted May 19, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Base-modified cytidine nucleotides for leukemia therapy2025
Cancer treatment with (2,2-bishydroxymethyl) methylenecyclopropane nucleotides2025
Cancer treatment with (2,2-bishydroxymethyl) methylenecyclopropane nucleotides2025
Dioxolane analogues of uridine for the treatment of cancer2022
Dioxolane analogues of uridine for the treatment of cancer2022
Dioxolane analogues of uridine for the treatment of cancer2022
Dioxolane analogues of uridine for the treatment of cancer2022
Sorafenib or regorafenib troxacitabine phosphoramidate prodrug combination thera2021
Sorafenib or regorafenib troxacitabine phosphoramidate prodrug combination thera2021
Sorafenib or regorafenib troxacitabine phosphoramidate prodrug combination thera2021
Dioxolane analogues of uridine for the treatment of cancer2020
Dioxolane analogues of uridine for the treatment of cancer2020